500 Istanbul (500 Emerging Europe)

500 Istanbul, now operating under the broader 500 Emerging Europe vehicle, is one of the most active early-stage funds in Turkey and the surrounding region, deploying $250k-$1M cheques at pre-seed, seed, and Series A into Turkish and CEE founders building global tech companies including digital health and health IT software. The firm benefits from the 500 Global network’s pattern recognition and follow-on capital across SaaS, fintech, and health tech, and operates with a programmatic approach that includes accelerator-style support alongside investment. For founders, 500 Emerging Europe is best positioned as an early generalist lead for Turkish or CEE operators building globally-ambitious software products with cross-border go-to-market potential. The right founder profile is a technically credible operator building B2B health software, AI-enabled clinical tools, or digital health platforms with early paid traction and a clear plan to expand into MENA, Western Europe, or the US. Founders running deep biotech, asset-heavy clinic chains, or single-country niche plays should not approach. Entry path is via a 500 portfolio CEO, the Istanbul founder community, the Bogazici and Koc University alumni networks, or warm introductions from co-investing Turkish and regional funds (Bogazici Ventures, ACT, Earlybird Digital East). In the pitch, lead with technical depth, paid customer logos, US and EU expansion plans, and a credible Series A narrative that names likely international leads. Caveats: Turkey’s macro and currency volatility constrain valuation expectations and follow-on round sizing, so founders should plan European or US leads early. AI focus is stated but commercial; AI-heavy founders should bring technical depth. Confirm reserves, current vintage, and pacing explicitly during diligence given 500’s broader vehicle restructuring.